First Quadrant’s Omega Protein OME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-24,400
Closed -$406K 1015
2017
Q3
$406K Buy
24,400
+400
+2% +$6.5K 0.01% 590
2017
Q2
$430K Sell
24,000
-20,718
-46% -$387K 0.01% 561
2017
Q1
$897K Buy
44,718
+42,418
+1,844% +$988K 0.02% 466
2016
Q4
$58K Hold
2,300
﹤0.01% 761
2016
Q3
$54K Hold
2,300
﹤0.01% 779
2016
Q2
$46K Hold
2,300
﹤0.01% 717
2016
Q1
$39K Hold
2,300
﹤0.01% 706
2015
Q4
$51K Hold
2,300
﹤0.01% 660
2015
Q3
$39K Sell
2,300
-2,500
-52% -$38.9K ﹤0.01% 700
2015
Q2
$66K Hold
4,800
﹤0.01% 665
2015
Q1
$66K Hold
4,800
﹤0.01% 632
2014
Q4
$51K Sell
4,800
-7,100
-60% -$84.1K ﹤0.01% 661
2014
Q3
$149K Buy
11,900
+1,700
+17% +$23.7K ﹤0.01% 581
2014
Q2
$140K Buy
+10,200
New +$133K ﹤0.01% 609

First Quadrant's OME Position: Q4 2017 in Review

First Quadrant sold out of Omega Protein (OME) in Q4 2017, closing a stake of 24,400 shares — an estimated $406K sold.

First Quadrant first reported a position in OME in Q2 2014 and held it in 14 quarters. The position peaked at $897K in Q1 2017. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.

  • First Quadrant reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
  • First Quadrant sold 24,400 Omega Protein shares in Q4 2017, an estimated $406K.
  • First Quadrant first reported a position in Omega Protein in Q2 2014 and held it in 14 quarters.
  • First Quadrant's Omega Protein position peaked at $897K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.

Based on First Quadrant's 13F filing for Q4 2017, filed 23 Jan 2018.